Search

everythinglearnresearchcommunity

for

Search:↓

Surgeons should evaluate new technologies critically, offer a range of services including non-surgical options, and be aware of marketing influences to meet patient needs and maintain a successful practice.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

UK stem-cell clinics often mislead about treatment safety and effectiveness, needing better regulation.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

People with alopecia areata may have a higher risk of blood clots.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Lichen planus may be associated with a higher risk of metabolic syndrome.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Eating fewer calories may slow aging and removing old cells can increase lifespan in mice.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

ATX-101 injections can cause hair loss.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Mogamulizumab can cause hair loss and skin rashes.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.